ID18382A - PHARMACEUTICAL COMPOSITION AND METHODS FOR TREATMENT OF COMPULSIF DISORDERS USING NAALADASE INHIBITORS - Google Patents
PHARMACEUTICAL COMPOSITION AND METHODS FOR TREATMENT OF COMPULSIF DISORDERS USING NAALADASE INHIBITORSInfo
- Publication number
- ID18382A ID18382A IDP972763A ID972763A ID18382A ID 18382 A ID18382 A ID 18382A ID P972763 A IDP972763 A ID P972763A ID 972763 A ID972763 A ID 972763A ID 18382 A ID18382 A ID 18382A
- Authority
- ID
- Indonesia
- Prior art keywords
- compulsif
- disorders
- treatment
- methods
- pharmaceutical composition
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3826—Acyclic unsaturated acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/718,703 US5824662A (en) | 1996-09-27 | 1996-09-27 | Treatment of global and focal ischemia using naaladase inhibitors |
US08/775,586 US5795877A (en) | 1996-12-31 | 1996-12-31 | Inhibitors of NAALADase enzyme activity |
US08/778,733 US5863536A (en) | 1996-12-31 | 1996-12-31 | Phosphoramidate derivatives |
US08/825,997 US5962521A (en) | 1997-04-04 | 1997-04-04 | Hydroxamic acid derivatives |
US08/835,572 US5902817A (en) | 1997-04-09 | 1997-04-09 | Certain sulfoxide and sulfone derivatives |
US08/842,360 US6054444A (en) | 1997-04-24 | 1997-04-24 | Phosphonic acid derivatives |
US08/858,985 US6025344A (en) | 1996-06-17 | 1997-05-27 | Certain dioic acid derivatives useful as NAALADase inhibitors |
US08/863,624 US6046180A (en) | 1996-06-17 | 1997-05-27 | NAALADase inhibitors |
US08/884,479 US6017903A (en) | 1996-09-27 | 1997-06-27 | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ID18382A true ID18382A (en) | 1998-04-02 |
Family
ID=27578904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDP972763A ID18382A (en) | 1996-09-27 | 1997-08-08 | PHARMACEUTICAL COMPOSITION AND METHODS FOR TREATMENT OF COMPULSIF DISORDERS USING NAALADASE INHIBITORS |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0949922A1 (en) |
JP (1) | JP2002514185A (en) |
AU (1) | AU4151897A (en) |
CA (1) | CA2264158A1 (en) |
ID (1) | ID18382A (en) |
WO (1) | WO1998013044A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054444A (en) | 1997-04-24 | 2000-04-25 | Guilford Pharmaceuticals Inc. | Phosphonic acid derivatives |
US6071965A (en) * | 1996-06-17 | 2000-06-06 | Guilford Pharmaceuticals Inc. | Phosphinic alkanoic acid derivatives |
US5977090A (en) * | 1996-09-27 | 1999-11-02 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors |
US5962521A (en) * | 1997-04-04 | 1999-10-05 | Guilford Pharmaceuticals Inc. | Hydroxamic acid derivatives |
WO1998053812A1 (en) * | 1997-05-27 | 1998-12-03 | Guilford Pharmaceuticals Inc. | Inhibitors of naaladase enzyme activity |
ID20347A (en) * | 1997-05-27 | 1998-12-03 | Guilford Pharm Inc | INHIBITOR ACTIVITIES OF NAALADASE ENZYMES |
DE69927502T2 (en) * | 1998-07-06 | 2006-07-06 | Mgi Gp, Inc. (N.D.Ges.D. Staates Delaware) | NAALADASE INHIBITORS APPLICABLE AS PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS |
CA2658200A1 (en) * | 1998-07-06 | 2000-01-13 | Mgi Gp, Inc. | Naaladase inhibitors useful as pharmaceutical compounds and compositions |
US6228888B1 (en) * | 1999-07-01 | 2001-05-08 | Guilford Pharmaceuticals Inc. | Methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors |
WO2001012184A1 (en) | 1999-08-16 | 2001-02-22 | Revaax Pharmaceuticals, Llc | Neurotherapeutic composition and method |
US6313159B1 (en) | 1999-08-20 | 2001-11-06 | Guilford Pharmaceuticals Inc. | Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors |
IL163935A0 (en) | 2002-03-21 | 2005-12-18 | Schering Ag | Plasma carboxypeptidase b inhibitors |
WO2004078180A2 (en) * | 2003-03-03 | 2004-09-16 | Guilford Pharmaceuticals Inc. | Naaladase inhibitors for treating opioid tolerance |
US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
JP5259970B2 (en) * | 2007-03-30 | 2013-08-07 | 学校法人九州文化学園 | Drug dependence treatment |
EP2338892A1 (en) | 2009-12-18 | 2011-06-29 | Bayer Schering Pharma Aktiengesellschaft | Prostate specific membrane antigen inhibitors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5500420A (en) * | 1993-12-20 | 1996-03-19 | Cornell Research Foundation, Inc. | Metabotropic glutamate receptor agonists in the treatment of cerebral ischemia |
-
1997
- 1997-08-08 ID IDP972763A patent/ID18382A/en unknown
- 1997-08-15 EP EP97939427A patent/EP0949922A1/en not_active Withdrawn
- 1997-08-15 CA CA002264158A patent/CA2264158A1/en not_active Abandoned
- 1997-08-15 AU AU41518/97A patent/AU4151897A/en not_active Abandoned
- 1997-08-15 JP JP51563698A patent/JP2002514185A/en not_active Ceased
- 1997-08-15 WO PCT/US1997/014417 patent/WO1998013044A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2264158A1 (en) | 1998-04-02 |
JP2002514185A (en) | 2002-05-14 |
AU4151897A (en) | 1998-04-17 |
WO1998013044A1 (en) | 1998-04-02 |
EP0949922A1 (en) | 1999-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA977090B (en) | Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors | |
ID18382A (en) | PHARMACEUTICAL COMPOSITION AND METHODS FOR TREATMENT OF COMPULSIF DISORDERS USING NAALADASE INHIBITORS | |
BR9611137A (en) | Compositions and methods for oral distribution of pharmaceutical agents | |
ID21332A (en) | METHODS AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF HYPERURICEMIA | |
FI971969A0 (en) | Compositions and method of use for the treatment of hemorrhoids | |
ES2178157T3 (en) | TREATMENT OF ARRITMIAS THROUGH THE INHIBITION OF A MULTIFUNCTIONAL KINASE PROTEIN DEPENDENT ON CALCIUM / CALMODULIN. | |
NZ333234A (en) | Phosphinyl derivatives useful as naaladase inhibitors and pharmaceutical compositions thereof for treating prostate diseases | |
BR1100403A (en) | Compound and pharmaceutical composition of cox-2 inhibitors | |
NO982809L (en) | Drugs of thrombin inhibitors | |
NO982311D0 (en) | Compositions and methods for the prevention and treatment of oral mucositis | |
IL124559A0 (en) | Metalloproteinase inhibitors pharmaceutical compositions containing them and their pharmaceutical uses and methods and intermediates useful for their preparation | |
HUP0000210A3 (en) | Heterocyclic compounds as metalloprotease inhibitors and use of them for producing pharmaceutical compisitions | |
IL128217A0 (en) | Phosphatase inhibitors and methods of use thereof | |
HU9700602D0 (en) | New inhibitors of bone-resorption and vitronectine-receptor-antagonists | |
NO972972L (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
ID25667A (en) | METHOD AND EQUIPMENT FOR WIDEBAND PREDISTORATION OF LINIERSATION | |
ZA988017B (en) | Parp inhibitors pharmaceutical compositions comprising same and methods of using same | |
HUP9902105A3 (en) | Pharmaceutical angiostatic dipeptide compositions and methods of use thereof | |
AUPO727097A0 (en) | Method of treatment of hepatoma and pharmaceutical compositions for use therein | |
DE69828345D1 (en) | Cross-correlation method and device for suppressing the effects of multiple scattering | |
EE9800234A (en) | Method of treatment and pharmaceutical composition | |
AU3005997A (en) | Inhibitors of picornavirus 3c proteases and methods for their use and preparation | |
PT927183E (en) | SPIROCYLIC INHIBITORS OF METALOPROTEASES | |
ID28460A (en) | COMPOSITION AND METHODS FOR TREATMENT AND PREVENTION OF BONE DISEASE USING TOCOTRIENOL | |
ID29547A (en) | METHODS AND COMPOSITIONS FOR TUBERCULOSIS PREVENTION AND TREATMENT |